Experimental thrombosis and Dextran 70
Viladés Juan, E.; Lasierra Cirujeda, J.; Fernández Clemente, J.J.
Angiologia 29(5): 214-220
1977
ISSN/ISBN: 0003-3170 PMID: 900560 Document Number: 111934
Document emailed within 1 workday
Related Documents
Haas, S.; Haas, P.; Blümel, G. 1988: Effect of actihaemyl-Dextran 40 on platelet function and thrombosis Fortschritte der Medizin 106(4): 76-80Vecsey, D.; Bánkuti, P. 1974: Prevention of Thrombosis. Results in urologic surgery using lower molecular dextran Die Medizinische Welt 25(5): 198-200
Darke, S.G. 1972: Ilo-femoral venous thrombosis after operations on the hip. a prospective controlled trial using dextran 70 Journal of Bone and Joint Surgery. British Volume 54(4): 615-620
Sukhanov, A.A.; Sukhanov, V.A. 1976: Use of law molecular weight dextran for prevention of thrombosis in surgical patients (review of the literature) Khirurgiia 1976(10): 133-135
Francis, C.W.; Pellegrini, V.D.; Marder, V.J.; Harris, C.M.; Totterman, S.; Gabriel, K.R.; Baughman, D.J.; Roemer, S.; Burke, J.; Goodman, T.L. 1989: Prevention of venous thrombosis after total hip arthroplasty. Antithrombin III and low-dose heparin compared with dextran 40 Journal of Bone and Joint Surgery. American Volume 71(3): 327-335
Francis, C.W.; Pellegrini, V.D.; Stulberg, B.N.; Miller, M.L.; Totterman, S.; Marder, V.J. 1990: Prevention of venous thrombosis after total knee arthroplasty. Comparison of antithrombin III and low-dose heparin with dextran Journal of Bone and Joint Surgery. American Volume 72(7): 976-982
Verstraete, M. 1976: Prevention of postoperative deep vein thrombosis and pulmonary embolism by low-dose heparin injection or by dextran Semaine des Hopitaux. Therapeutique 52(7-8): 389-394
Wiig, J.N.; Solhaug, J.H.; Bilberg, T.; Bjerkeset, T.; Edwin, B.; Grüner, O.P.; Havig, O.; Holter, O.; Knudsen, G.; Lundblad, R. 1995: Prophylaxis of venographically diagnosed deep vein thrombosis in gastrointestinal surgery. Multicentre trials 20 mg and 40 mg enoxaparin versus dextran European Journal of Surgery 161(9): 663-668
Harris, W.H.; Athanasoulis, C.A.; Waltman, A.C.; Salzman, E.W. 1985: Prophylaxis of deep-vein thrombosis after total hip replacement. Dextran and external pneumatic compression compared with 1.2 or 0.3 gram of aspirin daily Journal of Bone and Joint Surgery. American Volume 67(1): 57-62
Wu, X.; Ling, Q. 1998: Experimental colitis induced by dextran sulfate sodium Hunan Yi Ke da Xue Xue Bao 23(4): 359-360; 364
Suemasu, K.; Ishikawa, S. 1970: Inhibitive effect of heparin and dextran sulfate on experimental pulmonary metastases Gan 61(2): 125-130
Bhoopalam, N.; Heller, P.; Meyerstein, N.; Hall, L. 1980: Effect of dextran-S (alpha, 1-3 dextran) on the growth of plasmacytomas MOPC-104E and J558 Journal of Immunology 125(4): 1454-1458
Salvati, E.A.; Lachiewicz, P. 1976: Thromboembolism following total hip-replacement arthroplasty. the efficicy of dextran-aspirin and dextran-warfarin in prophylaxis Journal of Bone and Joint Surgery. American Volume 58(7): 921-925
Simon, S.; Schönné, F.I. 1975: Kinetics of changes in dextran concentration in the blood of rabbits following administration of dextran preparations of various molecular weights Acta Pharmaceutica Hungarica 45(3): 120-127
Muntané, J.; Puig-Parellada, P.; Mitjavila, M.T. 1995: Iron metabolism and oxidative stress during acute and chronic phases of experimental inflammation: effect of iron-dextran and deferoxamine Journal of Laboratory and Clinical Medicine 126(5): 435-443
Petrovický, P. 1988: Double-labelled nigral compacta and reticulata cells from injections in the reticular formation and in the striatum. An experimental study using retrograde double labelling with HRP and iron-dextran in the rat Journal für Hirnforschung 29(3): 243-253
Hladovec, J. 1972: Antithrombotic drugs and experimental thrombosis Cor et Vasa 20(2): 135-141
Knapp, W. 1974: Interactions of the third component of complement (C3) with cross-linked dextran. I. Binding of C3 from normal human serum to cross-linked dextran as defined by quantitative immunofluorescence Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 148(3): 213-224
Fedele, F. 2003: DEAE-Dextran in the treatment of primary hypercholesterolemia and/or hypercholesterolemia combined with hypertriglyceridemia. a multicentric randomized study on the efficacy of DEAE-Dextran compared with Cholestyramine La Clinica Terapeutica 154(4): 231-236
Poser, R.; Hirche, H. 1992: Randomized double-blind study of therapy of sudden deafness. Low molecular weight dextran + naftidrofuryl vs. low molecular weight dextran + placebo Hno 40(10): 396-399